FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377322007: Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3678001013 Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3678002018 Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3678003011 Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1202639013 Dehydrocholic acid + dimethicone + pancreatin 180mg/40mg/300mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1215538010 Dehydrocholic acid + dimethicone + pancreatin 180mg/40mg/300mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1478693014 Dehydrocholic acid+dimethicone+pancreatin 180mg/40mg/300mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3490450014 Product containing dehydrocholic acid 180 mg and dimeticone 40 mg and pancreatin 300 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3494263012 Product containing dehydrocholic acid 180 mg and dimeticone 40 mg and pancreatin 300 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3494264018 Product containing dehydrocholic acid 180 mg and dimethicone 40 mg and pancreatin 300 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3501652010 Dehydrocholic acid 180 mg and dimethicone 40 mg and pancreatin 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3501653017 Dehydrocholic acid 180 mg and dimeticone 40 mg and pancreatin 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3569255014 Product containing only dehydrocholic acid 180 mg and dimethicone 40 mg and pancreatin 300 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3569256010 Product containing only dehydrocholic acid 180 mg and dimeticone 40 mg and pancreatin 300 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3569257018 Product containing only dehydrocholic acid 180 mg and dimeticone 40 mg and pancreatin 300 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3678001013 Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3678002018 Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3678003011 Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3678004017 Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Is a Product containing dehydrocholic acid (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Is a pancréatine false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pancreatin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dehydrocholic acid (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bile false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Is a Product containing simeticone (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Simethicone false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet (dose form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Simethicone false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Simethicone false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength numerator value 40 false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pancreatin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Pancreatin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dehydrocholic acid (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Dehydrocholic acid (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength numerator value 180 false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Pancreatin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Dehydrocholic acid (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength numerator value 180 false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Simethicone false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has presentation strength numerator value 40 false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has unit of presentation Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has precise active ingredient Simethicone false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Is a Product containing dehydrocholic acid and pancreatin and simeticone in oral dosage form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has precise active ingredient Pancreatin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has precise active ingredient Dehydrocholic acid (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Count of base of active ingredient trois false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Is a Product containing only dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Plays role Digestant therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Back to Start